Abstract

Lymphatic leakage is an infrequent but relatively serious complication after resection of retroperitoneal tumors. Different approaches have been attempted in treatment of lymphatic leakage. However, to date none of them have been demonstrated consistently effective. We hereby report our preliminary experience with Lymphangiography and embolization for resolution of Lymphatic leakage after retroperitoneal tumor resection.The patient, a 55-year-old woman with massive retroperitoneal tumor, Computed tomography (CT) revealed that retroperitoneal cystadenoma. After the right ureteral stent was placed, the retroperitoneal tumor resection was performed, postoperatively she presented with lymphatic leakage unresponsive to several treatment measures. From the thirty-seven postoperative day (POD37), the patient underwent Lymphangiography and embolization, which resolved her lymphatic leakage.Lymphangiography is useful for detecting lymphatic leakage occurring after retroperitoneal tumor resection. Furthermore, lymphatic embolization is feasible, effective, and safe for managing leaks demonstrated on lymphangiography.

Highlights

  • The work has been reported in line with the SCARE criteria [1]

  • We hereby report a case of Lymphatic leakage after retroperitoneal tumor resection that was successfully resolved by Lymphangiography and embolization

  • Great attempt has been made to the treatment of lymphatic leakage, as listed in the following

Read more

Summary

Introduction

The work has been reported in line with the SCARE criteria [1]. The treatment of retroperitoneal tumor is frequently surgical resection and lymph node dissection. Lymphatic leakage following this is a common occurrence. A variety of approaches have been attempted to the treatment of lymphatic leakage. None has been consistently effective or optimal [2]. We hereby report a case of Lymphatic leakage after retroperitoneal tumor resection that was successfully resolved by Lymphangiography and embolization

Case presentation
Discussion
Ethical approval

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.